vivoPharm Overview

  • Founded
  • 2003
  • Status
  • Acquired/​Merged
  • Employees
  • 32
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $9.7M
Latest Deal Amount

vivoPharm General Information


Provider of a pre-clinical testing platform intended to offer pharmacology, toxicology and bioanalytical research services to guide drug development. The company's pre-clinical testing platform conducts tailored studies to guide drug development, starting from compound libraries and ending with a comprehensive set of in vitro, in vivo data and reports and also provides all services including toxicology testing and bionalytical analysis to GLP, enabling clients to to get treated in a better way in different disease areas.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Parent Company
Primary Office
  • Level 3 Office 29
  • 240 Plenty Road
  • Bundoora, Victoria 3083
  • Australia
+61 (03) 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

vivoPharm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 15-Aug-2017 $9.7M 00.00 00.00 Completed Profitable
3. Merger/Acquisition 31-Jan-2016 000.00 000.00 Cancelled Profitable
2. Corporate 26-Nov-2010 $1.3M $2.3M Completed Profitable
1. Seed Round 06-Feb-2008 $1M $1M Completed Startup
To view vivoPharm’s complete valuation and funding history, request access »

vivoPharm Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Provider of a pre-clinical testing platform intended to offer pharmacology, toxicology and bioanalytical research servic
Other Pharmaceuticals and Biotechnology
Bundoora, Australia
32 As of 2017
0.00 0000-00-00
000000&0 00.00


ulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mo
0000 000000000
Princeton, NJ
000 As of 0000
0000 0000-00-00
000000&0 00000


ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore e
0000 000000000
Freiburg, Germany
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

vivoPharm Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aptuit Formerly PE-Backed Princeton, NJ 000 00000 000000&0 00000
000000000 Formerly PE-Backed Freiburg, Germany 000000&0
00000000000 Corporation Rockville, MD 000000000 -
000000000 00000000 Private Equity-Backed Nottingham, United Kingdom 000 0000000 0000
To view vivoPharm’s complete competitors history, request access »

vivoPharm Executive Team (5)

Name Title Board Seat Contact Info
Sabine Brandt Co-Founder & Executive Finance Manager
Melanie Keller Division Head, Europe
Chris Holding Division Head of Efficacy Testing
Joanne Chua Ph.D Division Head of Toxicology and Pharmacology Australia
Glenn Smits Ph.D Senior Vice President, Discovery and Early Development
To view vivoPharm’s complete executive team members history, request access »

vivoPharm Board Members (3)

Name Representing Role Since
Brenton Wright vivoPharm Board Member 000 0000
Ian Nisbet Ph.D vivoPharm Chairman 000 0000
Ralf Brandt Ph.D vivoPharm Co-Founder, Chief Executive Officer, Board Member & Managing Director 000 0000
To view vivoPharm’s complete board members history, request access »

vivoPharm Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

vivoPharm Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Terra Rossa Capital Venture Capital Minority 000 0000 000000 0
Wexford Equities Other Minority 000 0000 000000 0
To view vivoPharm’s complete investors history, request access »

vivoPharm Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 0000 00000000 11-Apr-2012 000000000000000000 Laboratory Services (Healthcare) 000 000000 00.0
To view vivoPharm’s complete acquisitions history, request access »